Regulation & law · 31/07/2013

Apertus Pharmaceuticals Submits Notice of Application to Manufacture Controlled Substances

Apertus Pharmaceuticals has submitted a notice of application to the regulatory authorities to manufacture controlled substances, as required by law, in accordance with the regulations set by the Drug Enforcement Administration (DEA)